Tylenol

Tylenol Maker Kenvue Beats Quarterly Profit Estimates, Announces Job Cuts

Kenvue beat Wall Street estimates for first-quarter profit and said it would cut 4% of its global workforce amid efforts to expand its key brands.

Tylenol Maker Kenvue Forecasts Annual Profit Below Estimates After Weak Quarter

Kenvue forecast full-year profit below analysts' expectations after missing quarterly sales estimates, as the Tylenol maker faces sluggish demand in China...

Kenvue Cuts Annual Profit Forecast On Soft Demand For Cold, Flu Medicines

Kenvue cut the higher end of its annual profit forecast, as the Benadryl maker saw weakness in demand for its cold and flu medicines and an increased impac...

J&J Unveils Name Of Consumer Health Business Ahead Of Spin-Off

Johnson & Johnson has named its consumer business Kenvue as it is moving ahead with its plans to spin-off the unit in what would be the biggest sha...

J&J Beats Profit Estimates But Cuts Forecast On Coronavirus Uncertainty

Johnson & Johnson beat analysts' estimates for first-quarter profit on higher sales of its cancer drugs and consumer products including Tylenol, wh...

Johnson & Johnson Edges Past Profit Estimates, Lifts Outlook

Johnson & Johnson has reported slightly better-than-expected quarterly profit, and pushed its full-year forecast higher. Overall sales for the B...

Subscribe Today

Get the app today!